Skip to main content
Book cover

Prostacyclin and Hypertension

  • Book
  • © 1990

Overview

  • 136 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (4 chapters)

Keywords

About this book

The aim of present-day treatment of hypertension is no longer as the effective reduction of blood pressure, regarded merely but as the ever-increasing application of new therapeutic prin­ ciples to prevent such consequences of hypertension as left heart hypertrophy, medial hypertrophy of the vessels and ar­ teriosclerosis. In this context special attention has been di­ rected to stimulation of the endogenous vasocilator hormonal systems such as the prostaglandins. The great interest in our book, which has meanwhile appeared in a French edition, seems to confirm this trend and has encouraged us to include in the book the new findings published in the last twelve months. These changes and additions maintain the current status of the book and provide an even more complete survey of the available information about prostacyclin in hyperten­ sion. We wish to thank all those colleagues who have made useful suggestions for this second edition, as well as Springer­ Verlag and its associates, who ensured a uniformly smooth passage in the production of the book. Cologne and MUnster, January 1990 Gerd Bonner Karl-Heinz Rahn v Preface to the First Edition Diseases of the heart and circulation currently constitute the commonest causes of death in our population. Hypertension, as evidenced by a pathologic increase in blood pressure, is one of the most important risk factors. Primary hypertension can be established in about 15 % of adults. Patients with hyperten­ sion usually feel well subjectively and only rarely complain of symptoms.

Authors and Affiliations

  • Medizinische Universitätsklinik II, Städtische Krankenanstalten Merheim, Köln 91, Germany

    Gerd Bönner

  • Medizinische Poliklinik, Universität Münster, Münster, Germany

    Karl-Heinz Rahn

Bibliographic Information

Publish with us